It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
LABFF’s FA Score shows that 2 FA rating(s) are green whileQSI’s FA Score has 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
QSI’s TA Score shows that 4 TA indicator(s) are bullish.
LABFF (@Pharmaceuticals: Generic) experienced а 0.00% price change this week, while QSI (@Medical/Nursing Services) price change was -13.39% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +4.25%. For the same industry, the average monthly price growth was +10.98%, and the average quarterly price growth was +78.05%.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +1.37%. For the same industry, the average monthly price growth was +2.38%, and the average quarterly price growth was +4.58%.
QSI is expected to report earnings on Nov 05, 2025.
A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.
@Medical/Nursing Services (+1.37% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
LABFF | QSI | LABFF / QSI | |
Capitalization | 3.38B | 223M | 1,515% |
EBITDA | 203M | -105.87M | -192% |
Gain YTD | 0.000 | -59.259 | - |
P/E Ratio | 28.85 | N/A | - |
Revenue | 749M | 3.44M | 21,754% |
Total Cash | 47.6M | 233M | 20% |
Total Debt | 129M | 12.1M | 1,066% |
LABFF | QSI | |
---|---|---|
RSI ODDS (%) | N/A | 1 day ago78% |
Stochastic ODDS (%) | N/A | 1 day ago87% |
Momentum ODDS (%) | N/A | 1 day ago87% |
MACD ODDS (%) | N/A | 1 day ago90% |
TrendWeek ODDS (%) | 1 day ago14% | 1 day ago88% |
TrendMonth ODDS (%) | 1 day ago14% | 1 day ago89% |
Advances ODDS (%) | N/A | 24 days ago79% |
Declines ODDS (%) | N/A | 1 day ago90% |
BollingerBands ODDS (%) | N/A | 1 day ago87% |
Aroon ODDS (%) | N/A | 1 day ago90% |
A.I.dvisor indicates that over the last year, LABFF has been closely correlated with IMRN. These tickers have moved in lockstep 81% of the time. This A.I.-generated data suggests there is a high statistical probability that if LABFF jumps, then IMRN could also see price increases.
Ticker / NAME | Correlation To LABFF | 1D Price Change % | ||
---|---|---|---|---|
LABFF | 100% | N/A | ||
IMRN - LABFF | 81% Closely correlated | -0.55% | ||
MNMD - LABFF | 47% Loosely correlated | -1.13% | ||
CELZ - LABFF | 35% Loosely correlated | +1.63% | ||
NVO - LABFF | 29% Poorly correlated | +2.87% | ||
QSI - LABFF | 26% Poorly correlated | -1.79% | ||
More |
A.I.dvisor indicates that over the last year, QSI has been loosely correlated with AXON. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if QSI jumps, then AXON could also see price increases.
Ticker / NAME | Correlation To QSI | 1D Price Change % | ||
---|---|---|---|---|
QSI | 100% | -1.79% | ||
AXON - QSI | 49% Loosely correlated | +0.59% | ||
VCYT - QSI | 47% Loosely correlated | +0.60% | ||
NNOX - QSI | 45% Loosely correlated | -1.78% | ||
MESO - QSI | 39% Loosely correlated | +2.46% | ||
ARRY - QSI | 39% Loosely correlated | +25.33% | ||
More |